| Product Code: ETC9517121 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Neuroblastoma Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Neuroblastoma Market - Industry Life Cycle |
3.4 Suriname Neuroblastoma Market - Porter's Five Forces |
3.5 Suriname Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Suriname Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Suriname Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Suriname Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma and its early detection in Suriname |
4.2.2 Advances in medical technology and treatment options for neuroblastoma |
4.2.3 Growing investments in healthcare infrastructure in Suriname |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers for neuroblastoma in Suriname |
4.3.2 High treatment costs and financial burden on patients and families |
4.3.3 Lack of skilled healthcare professionals with expertise in neuroblastoma care in Suriname |
5 Suriname Neuroblastoma Market Trends |
6 Suriname Neuroblastoma Market, By Types |
6.1 Suriname Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Suriname Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Suriname Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Suriname Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Suriname Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Suriname Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Suriname Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Suriname Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Suriname Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Suriname Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Suriname Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Suriname Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Suriname Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Suriname Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Suriname Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Suriname Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Suriname Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Neuroblastoma Market Import-Export Trade Statistics |
7.1 Suriname Neuroblastoma Market Export to Major Countries |
7.2 Suriname Neuroblastoma Market Imports from Major Countries |
8 Suriname Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Suriname |
8.2 Number of early-stage neuroblastoma diagnoses in Suriname |
8.3 Patient satisfaction with neuroblastoma treatment and care in Suriname |
9 Suriname Neuroblastoma Market - Opportunity Assessment |
9.1 Suriname Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Suriname Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Suriname Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Suriname Neuroblastoma Market - Competitive Landscape |
10.1 Suriname Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Suriname Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here